bromfenac has been researched along with Cataract in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlawat, P; Dharamsi, A; Patel, A; Patel, M; Patel, S; Saha, N | 1 |
| Visco, DM | 1 |
| Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
| Baek, SK; Lee, MW; Lee, YH; Song, SH | 1 |
| Ciulla, T; Harris, A; Price, F; Siesky, B; Wentz, SM | 1 |
| Beral, L; David, T; Finke, E; Glatre, F; Troumani, Y | 1 |
| Maruyama, Y; Masuda, A; Miyata, K; Nejima, R; Terada, Y | 1 |
| Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY | 1 |
| Cavuto, S; Cimino, L; Coassin, M; Fontana, L; Formisano, D; Iovieno, A; Sartori, A; Soldani, A | 1 |
| Choi, EY; Kang, HG; Kim, EK; Kim, TI; Lee, HK | 1 |
| Levitz, L | 1 |
| Chen, H; Chen, W; Li, J; Lin, H; Xiang, W; Zhang, B | 1 |
| Aose, M; Gotoh, N; Matsui, E; Matsushima, H; Mukai, K; Nagata, M; Satoshi, W; Senoo, T; Wataru, T | 1 |
| Bucci, FA; Waterbury, LD | 1 |
2 review(s) available for bromfenac and Cataract
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Clinical Trials as Topic; Drug Compounding; Humans; Inflammation; Pain, Postoperative; Treatment Outcome | 2019 |
6 trial(s) available for bromfenac and Cataract
| Article | Year |
|---|---|
[The anti-inflammatory effect of 0.1% bromfenac and 0.1% betamethasone combination in post-cataract surgery patients with diabetes mellitus].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Benzophenones; Betamethasone; Bromobenzenes; Cataract; Cataract Extraction; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Macular Edema; Male; Middle Aged; Postoperative Complications | 2014 |
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Female; Humans; Inflammation; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Miosis; Phacoemulsification; Postoperative Complications; Postoperative Period; Premedication; Treatment Outcome | 2015 |
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Exfoliation Syndrome; Humans; Lens Implantation, Intraocular; Ophthalmic Solutions; Postoperative Complications | 2016 |
Effect of postoperative administration of nonsteroidal antiinflammatory drugs and steroids on the conformational changes in wound healing after cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Cornea; Humans; Lens Implantation, Intraocular; Prednisolone; Prospective Studies; Wound Healing | 2016 |
Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E
Topics: Administration, Topical; Aged; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Double-Blind Method; Female; Humans; Intraoperative Complications; Lasers; Male; Middle Aged; Miosis; Prospective Studies; Receptors, Prostaglandin E, EP2 Subtype; Time Factors | 2017 |
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2011 |
6 other study(ies) available for bromfenac and Cataract
| Article | Year |
|---|---|
Development of Bromfenac Sodium Loaded Pluronic Nanomicelles: Characterization and Corneal Permeation Study.
Topics: Animals; Benzophenones; Bromobenzenes; Cataract; Cornea; Hyaluronic Acid; Micelles; Particle Size; Poloxamer; Rabbits | 2022 |
Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Dexamethasone; Humans; Incidence; Iritis; Ketorolac; Macular Edema; Pain; Photophobia; Postoperative Complications; Retrospective Studies | 2023 |
Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2020 |
[One case of corneal melting after instillation of bromfenac 0.09%].
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Corneal Edema; Corneal Perforation; Corneal Ulcer; Descemet Membrane; Emergencies; Fibrin Tissue Adhesive; Gastrointestinal Hemorrhage; Hernia; Humans; Instillation, Drug; Iris Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Peptic Ulcer Perforation; Postoperative Complications; Tomography, Optical Coherence | 2014 |
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Exfoliation Syndrome; Humans; Ophthalmic Solutions | 2016 |
Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Betamethasone; Bromobenzenes; Cataract; Diclofenac; Glucocorticoids; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Rabbits; Treatment Outcome | 2009 |